<?xml version="1.0" encoding="UTF-8"?>
<ref id="cit0020">
 <label>20.</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Dahlén</surname>
   <given-names>E</given-names>
  </string-name>, 
  <string-name>
   <surname>Veitonmäki</surname>
   <given-names>N</given-names>
  </string-name>, 
  <string-name>
   <surname>Norlén</surname>
   <given-names>P</given-names>
  </string-name>. 
  <article-title>Bispecific antibodies in cancer immunotherapy</article-title>. 
  <source>
   <italic toggle="yes">Ther Adv Vaccines Immunother</italic>
  </source>. 
  <year>2018</year>;
  <volume>6</volume>(
  <issue>1</issue>):
  <fpage>3</fpage>–
  <lpage>17</lpage>. doi:
  <pub-id pub-id-type="doi">10.1177/2515135518763280</pub-id>
  <pub-id pub-id-type="pmid">29998217</pub-id>
 </mixed-citation>
</ref>
